Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06446947

Identification of Markers of Poor Clinical Prognosis in Sepsis by Epigenetic Analysis

Sponsor: Assistance Publique Hopitaux De Marseille

View on ClinicalTrials.gov

Summary

Sepsis is a multifactorial syndrome characterized by a dynamic course and a clinical outcome dependent on several factors, and responsible for one in five deaths worldwide. The aim of this trial is to identify new prognostic markers for the progression of sepsis to septic shock, by comparing epigenetic markers between patients who have or have not developed severe forms of sepsis. The main objective of this preliminary study is to identify prognostic markers for the progression of sepsis to septic shock, i.e. to compare targeted markers between subjects with sepsis who progress to septic shock versus subjects with sepsis who do not progress to septic shock.

Official title: Identification de Marqueurs de Mauvais Pronostic Clinique du Sepsis Par Analyse épigénétique.

Key Details

Gender

MALE

Age Range

45 Years - 75 Years

Study Type

OBSERVATIONAL

Enrollment

25

Start Date

2025-03-20

Completion Date

2026-09-30

Last Updated

2026-02-12

Healthy Volunteers

No

Interventions

OTHER

blood sampling

Blood sampling (6ml) on admission and a second on discharge from intensive care.

Locations (1)

Service Anesthésie Réanimation - Hôpital Nord - Assistance Publique Hôpitaux de Marseille

Marseille, Bouches du Rhône, France